Form 6-K SMITH & NEPHEW PLC For: Apr 16
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
April
16, 2026
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s
name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F ✔
Form 40-F
__
SMITH & NEPHEW PLC
16 April 2026
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse
Regulation (Regulation (EU) 596/2014, as it forms part of domestic
law by virtue of the European Union (Withdrawal) Act
2018).
AWARD MADE UNDER THE SMITH & NEPHEW PLC RISE SHARE
PLAN
As a part of RISE strategy, the following awards of US$0.20
ordinary shares (the "Shares") in Smith & Nephew plc (the
"Company") were granted on 15 April 2026, under the Company's RISE
Share Plan, a sub-plan of the Smith & Nephew plc Restricted
Share Plan 2024.
|
Reason for the notification
|
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Awards granted on 15 April 2026 under the Smith & Nephew plc
RISE Share Plan.
|
|
Date of Transaction
|
2026 - 04 - 15
|
|
Place of Transaction
|
Grant took place outside a trading venue
|
|
Name (Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Deepak Nath
(Chief Executive Officer)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
John Rogers
(Chief Financial Officer)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Helen Barraclough
(Group General Counsel and Company Secretary)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Ajay Dhankhar
(Chief Strategy & Corporate Development
Officer)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Craig Gaffin
(President Global Orthopaedics)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Rohit Kashyap
(President AWM and Global Commercial Operations)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Mizanu Kebede
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Vasant Padmanabhan
(President Research & Development, ENT & Emerging
Markets)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Alison Parkes
(Chief Compliance Officer)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
|
Scott Schaffner
(Global President Sports Medicine)
|
PDMR
|
Nil
|
50
|
N/A Single Transaction
|
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
April 16, 2026
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|